Linhua F. Yang

No.382 Wuyi Road
Taiyuan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Blood Glucose Trajectories and Mortality in Sepsis-Induced Coagulopathy: A Latent Growth Mixture Modeling Analysis.

Blood Glucose Trajectories and Mortality in Sepsis-Induced Coagulopathy: A Latent Growth Mixture Modeling Analysis.

Journal: Shock (Augusta, Ga.)

Published: May 22, 2026

Olverembatinib-Based Therapy in Patients With Transformed Chronic Myeloid Leukemia in Lymphoid Blast Phase or Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study.

Olverembatinib-Based Therapy in Patients With Transformed Chronic Myeloid Leukemia in Lymphoid Blast Phase or Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 07, 2026

Pathogenic Variant VWF-Cys2750Phe in CK Domain Caused Type 2A VWD by Impairing VWF Multimerization and Secretion.

Pathogenic Variant VWF-Cys2750Phe in CK Domain Caused Type 2A VWD by Impairing VWF Multimerization and Secretion.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 09, 2025

Clinical characteristics and genetic variant spectrum of 27 patients with coagulation factor XI deficiency.

Clinical characteristics and genetic variant spectrum of 27 patients with coagulation factor XI deficiency.

Journal: Human genetics

Published: September 07, 2025

Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.

Hetrombopag for patients with persistent primary immune thrombocytopenia: a post hoc analysis of a multicenter, randomized phase Ⅲ trial.

Journal: Research and practice in thrombosis and haemostasis

Published: July 03, 2025

Pathogenic mechanisms and targeted therapies for anemia in myelodysplastic syndromes.

Pathogenic mechanisms and targeted therapies for anemia in myelodysplastic syndromes.

Journal: Leukemia research

Published: June 17, 2025

Gene variants in a family with inherited coagulation factor XI deficiency and identification of novel mutations.

Gene variants in a family with inherited coagulation factor XI deficiency and identification of novel mutations.

Journal: Thrombosis research

Published: May 28, 2025

Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025).

Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025).

Journal: Blood science (Baltimore, Md.)

Published: May 22, 2025

Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.

Olverembatinib in accelerated-phase chronic myeloid leukemia: efficacy and safety evaluation.

Journal: Haematologica

Published: May 15, 2025

Cancer therapy-induced senescence: A critical yet overlooked aspect.

Cancer therapy-induced senescence: A critical yet overlooked aspect.

Journal: Chinese medical journal

Published: May 14, 2025

Targeting ferroptosis and cuproptosis in gastrointestinal cancers: molecular mechanisms, metabolic vulnerabilities, and therapeutic interventions.

Targeting ferroptosis and cuproptosis in gastrointestinal cancers: molecular mechanisms, metabolic vulnerabilities, and therapeutic interventions.

Journal: Molecular biomedicine

Published: April 15, 2025

Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials.

Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials.

Journal: Nature medicine

Published: March 02, 2025

Showing 1-12 of 106

Last Updated: 09/26/2026